These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17667593)

  • 1. Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells.
    Puglisi F; Andreetta C; Valent F; Minisini AM; Rijavec E; Russo S; Mansutti M; Cardellino G; Pizzolitto S; Di Loreto C
    Anticancer Drugs; 2007 Sep; 18(8):883-8. PubMed ID: 17667593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducible immunohistochemical criteria based on multiple raters' judgments for expression of thymidine phosphorylase in breast cancer tissue.
    Tsuda H; Akiyama F; Kurosumi M; Sakamoto G
    Breast Cancer Res Treat; 2004 Aug; 86(3):215-23. PubMed ID: 15567938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of thymidine phosphorylase expression in stromal cells around invasive front of rectal cancer.
    Kobayashi T; Kawahara H; Koido S; Kobayashi S; Kashiwagi H; Yanaga K
    Hepatogastroenterology; 2008; 55(88):2045-8. PubMed ID: 19260474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.
    Kurosumi M; Sugamata N; Tabei T; Inoue K; Matsumoto H; Suemasu K; Higashi Y
    Anticancer Res; 2002; 22(1A):331-8. PubMed ID: 12017313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of thymidine phosphorylase in gastric cancer: is there a role of the differential expression in tumor cells and associated stromal cells?
    Liakakos T; Troupis T; Ghiconti I; Triantafyllidis S; Macheras A; Karatzas G; Pavlakis K
    Anticancer Res; 2006; 26(5B):3899-903. PubMed ID: 17094420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
    Herceg D; Vrbanec D
    Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular dysfunction and urinary zinc excretion in breast cancer patients treated with anthracycline-based combination chemotherapy.
    Králícková P; Melichar B; Malír F; Roubal T
    J Exp Clin Cancer Res; 2004 Dec; 23(4):579-84. PubMed ID: 15743027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
    Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
    J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
    Kim TD; Li G; Song KS; Kim JM; Kim JS; Kim JS; Yun EJ; Park JI; Park HD; Hwang BD; Lim K; Yoon WH
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):853-60. PubMed ID: 19215821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
    Rocca A; Viale G; Gelber RD; Bottiglieri L; Gelber S; Pruneri G; Ghisini R; Balduzzi A; Pietri E; D'Alessandro C; Goldhirsch A; Colleoni M
    Cancer Chemother Pharmacol; 2008 May; 61(6):965-71. PubMed ID: 17639392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological markers as predictive factors of response to neoadjuvant taxanes and anthracycline chemotherapy in breast carcinoma.
    Zhou B; Yang DQ; Xie F
    Chin Med J (Engl); 2008 Mar; 121(5):387-91. PubMed ID: 18364105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of the enzymes of DNA metabolism in the blood of patients with breast cancer].
    Borzenko BG; Gorbachev AA; Dumanskiĭ IuV; Shevchenko VV; Shepliakov MN
    Vopr Onkol; 1990; 36(1):17-23. PubMed ID: 2154896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.
    Bartsch R; Steger GG; Forstner B; Wenzel C; Pluschnig U; Rizovski B; Altorjai G; Zielinski CC; Mader RM
    BMC Clin Pharmacol; 2007 Jul; 7():7. PubMed ID: 17640356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
    Tang SC
    Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
    Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
    J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
    Cuppone F; Bria E; Carlini P; Milella M; Felici A; Sperduti I; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
    Cancer; 2008 Jul; 113(2):238-46. PubMed ID: 18470908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
    Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
    Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
    Moreno-Aspitia A; Perez EA
    Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
    Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
    Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
    Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.